Symposium to present the ARTiMIS Alliance
ARTiMIS is an alliance between HMS and Moderna Therapeutics to provide access to a novel platform for mRNA delivery to immune cells.
ARTiMIS will also offer funding for pilot projects and the opportunity to collaborate with Moderna scientists.
Thursday, September 26, 2019
12:30 PM – 4:00 PM (reception to follow)
Harvard Medical School
New Research Building, Room 1031
77 Avenue Louis Pasteur, Boston
Welcome Remarks
Arlene Sharpe: Chair, Department of Immunology
David Golan: Dean for Research Operations & Global Programs
Introduction to ARTiMIS
Uli von Andrian: ARTiMIS Program Director
Introduction to Moderna
Stephen Hoge: President, Moderna
Overview of Platform
Melissa Moore: Chief Scientific Officer, Research Platform, Moderna
Examples of Platform Use in Mammalian Immune Cells
Gilles Besin: Senior Director of Immunology, Moderna
Introduction to Additional Moderna Research Areas
Josh Frederick: Head of Oncology Research
Eric Huang: Chief Scientific Officer, New Venture Labs
Andrea Carfio: Head, Infectious Disease Research
For more information about Moderna Therapeutics, please visit their website.
